Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer
Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
The present study aims to investigate a proactive strategy including Salovum™ and SPC-flakes
to prevent the occurrence of abemaciclib-induced diarrhea in patients with early breast
cancer.